Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MT4 Cell Antiviral Assay from US Patent US10064873: "Compounds and compositions for treating HIV with derivatives of Betulin"
Assay data:74 Active, 5 Activity ≤ 1 nM, 74 Activity ≤ 1 µM, 74 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Anti-HIV activity against HIV-1 NL4-3 Nanoluc-sec virus infected in human MT4 cells assessed as viral growth inhibition by measuring luciferase activity measured after 3 days post-infection by Nano-Glo luciferase assay
Assay data:13 Active, 1 Activity ≤ 1 nM, 13 Activity ≤ 1 µM, 13 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Antiviral activity against NNRTI resistant HIV1 LAI infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect measured after 5 days by MTT assay
Assay data:2 Active, 1 Activity ≤ 1 nM, 2 Activity ≤ 1 µM, 2 Tested
Antiviral activity against NNRTI resistant HIV1 harboring Gly190Ala mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect measured after 5 days by MTT assay
Antiviral activity against NNRTI resistant HIV1 harboring Tyr188Leu mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect measured after 5 days by MTT assay
Assay data:3 Active, 3 Activity ≤ 1 µM, 3 Tested
Antiviral activity against NNRTI resistant HIV1 harboring Tyr181Cys mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect measured after 5 days by MTT assay
Antiviral activity against NNRTI resistant HIV1 harboring Val106Ala mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect measured after 5 days by MTT assay
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
Antiviral activity against NNRTI resistant HIV1 harboring Lys103Asn mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect measured after 5 days by MTT assay
Antiviral activity against NNRTI resistant HIV1 harboring Leu100IIe mutant infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect measured after 5 days by MTT assay
Antiviral activity against wild type HIV1 IIIB assessed as viral growth inhibition measured after 5 days by MTT assay
Antiviral activity against HIV-1 NL4-3 infected in PBMC (unknown origin) assessed as reduction in viral replication
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed Citation
Antiviral activity against HIV-1 NL4-3 infected in human H9 cells assessed as reduction in viral replication at MOI of 0.03 measured after 48 hrs by Bright-Glo Luciferase Assay
Antiviral activity against recombinant HIV-1 infected in CD4+ human HeLa cells assessed as reduction in viral replication
Assay data:3 Active, 3 Tested
Potency index, ratio of D-alaninyl analog EC50 to test compound EC50 for antiviral activity against HIV-1 IIIb infected in human MT2 cells
Assay data:1 Tested
SummaryPubMed Citation
Antiviral activity against HIV-1 IIIb infected in human MT2 cells assessed as reduction in virus induced cytopathic effect and measured after 5 days by XTT assay
Assay data:3 Active, 1 Activity ≤ 1 µM, 3 Tested
Antiviral activity against HIV-1 assessed as viral growth inhibition
Inhibition of Influenza A virus (A/Wisconsin/09/2013(HIN1)) recombinant Neuraminidase using MUNANA as substrate incubated for 60 mins by fluorescence based assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Antiviral activity against HIV-1 IIIB infected in human MT4 cells assessed as inhibition of viral replication measured after 5 days by Celltiter-Glo assay
Assay data:6 Active, 6 Activity ≤ 1 µM, 6 Tested
Antiviral activity against HIV-1 IIIB infected in human MT4 cells assessed as inhibition of virus-induced cell death preincubated for 1 hr with compound followed by viral infection measured after 5 days by MTT assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 3 Tested
Inhibition of wild type HIV1 protease expressed in Escherichia coli BL21 DE3 assessed as cleavage of fluorogenic substrate using EDANS-RESGIFLETSKR-DABCYL preincubated for 15 mins with compound followed by substrate addition and measured after 60 mins by microplate reader analysis
Assay data:3 Active, 2 Activity ≤ 1 µM, 7 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on